Table 6.
Investigator assessed best overall response
| Best response according to medical judgment | Everolimus (N = 120), n (%) |
|---|---|
| Complete response | 0 (0.0) |
| Partial response | 81 (67.5) |
| Stable disease | 35 (29.2) |
| Progressive disease | 1 (0.8) |
| Unknown | 3 (2.5) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.